Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers.
Parataxis Holdings, an affiliate of digital asset-focused investment firm Parataxis Capital Management, is set to launch a Bitcoin-native treasury platform in the South Korean public market.
The firm announced on June 20 that it had entered a definitive agreement to invest 29 billion South Korean won ($18.5 million) into Bridge Biotherapeutics, a publicly traded biotech company.
Following the acquisition, Parataxis will take a controlling interest in the firm, which will be renamed Parataxis Korea and repurposed as a treasury vehicle for institutional Bitcoin (BTC) exposure.
Read more
If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.
If you want to read more News articles, you can visit our General category.
